ferric carboxymaltose
Commercial- Indications
- Iron deficiency
Company intelligence / Profile preview
WBCIL has over six decades of experience in manufacturing active pharmaceutical ingredients and fine chemicals. The company holds multiple patents for innovative mineral-based APIs and advanced delivery systems such as liposomal formulations. Its products are commercialized globally across more than thirty countries. WBCIL was recognized with the National Intellectual Property Award in India for patent filing and commercialization in healthcare innovation. The company’s portfolio includes injectable iron APIs, liposomal minerals/vitamins for enhanced bioavailability, DC grades/premixes for pharma/nutraceutical use; it maintains WHO-GMP/ISO/HACCP certifications.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on West Bengal Chemical Industries.